News
Comparison of 5 Beta-Blockers in Heart Failure with Reduced Ejection Fraction
An analysis of 26 studies with beta-blockers in the treatment of heart failure with reduced ejection fraction compared 5 drugs (bisoprolol, metoprolol-succinate, metoprolol-tartrate, carvedilol, and nebivolol). The results showed a more favorable prognosis with bisoprolol compared to carvedilol, a similar effect on prognosis for carvedilol, metoprolol-succinate, and nebivolol, and the least favorable prognosis with metoprolol-tartrate.
Interactive Case Study: Treatment of Neuropathic Pain in a Patient with Neurodegenerative Disease
We offer a brief case study of a polymorbid patient suffering from chronic pain, spasticity, and sleep...
Long-term Benefit of Luspatercept Therapy – Fresh Data from the MEDALIST Study
The goal of therapy for low-risk myelodysplastic syndrome (MDS) is to compensate for anemia,…
Use of Medical Cannabis in Patients with Fibromyalgia to Relieve Pain and Depression
Medical cannabis is prescribed to patients with chronic pain resistant to conventional treatments.…
Pilot Program for Lung Cancer Screening in the Czech Republic – Current Interim Results
Since January 1, 2022, a pilot population program for lung cancer screening has been underway in…
Under the Microscope: How is Patient Care for Heart Failure in the Czech Republic in Real Practice?
The journal Vnitřní lékařství recently published the results of a survey conducted among outpatient…
Artificial Intelligence Helps in Selecting Influenza Strains for Vaccine Production
Vaccination is one of the most important and effective preventive measures in the fight against…
Central European Expert Consensus on the Treatment of ITP in Adult Patients
In a recently published consensus, experts from Central Europe evaluate the current treatment…
How do patients perceive the treatment of ITP with romiplostim?
Romiplostim, along with eltrombopag and avatrombopag, belongs to the group of thrombopoietin…
FDA Warns Against Self-Monitoring Glucose Using Smartwatches. What About in Czechia?
On February 21st, the U.S. Food and Drug Administration (FDA) issued a warning aimed at diabetic…